Nicoletta Colombo, MD, PhD
Associate Professor of Obstetrics and Gynecology
European Institute of Oncology
University of Milan-Bicocca
Nicoletta Colombo, MD, PhD, has disclosed that she has received consulting fees from AstraZeneca, BIOCAD, Clovis Oncology, Eisai, GlaxoSmithKline, ImmunoGen, Mersana, MSD/Merck, Novartis, Pfizer, Pharmamar, Roche, Takeda, and Tesaro.
David Scott Miller, MD, FACOG, FACS, has disclosed that he has received consulting fees from AbbVie, AstraZeneca, Eisai, EMD Serono, GlaxoSmithKline, Incyte, iTeos Belgium SA, Myriad Genetics, Novocure, Seagen, Tarveda, and Tesaro and funds for research support from Advenchen, Agenus, AKESOBIO Australia PTY, Eisai Europe Limited, EMD Serono, Karyopharm, Merck Sharp & Dohme, Novocure, and Tesaro.
Shannon N. Westin, MD, MPH
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Shannon N. Westin, MD, MPH, has disclosed that she has received consulting fees from Agenus, AstraZeneca, Clovis Oncology, Eisai, EQRx, GlaxoSmithKline, Lilly, Merck, Mereo, Novartis, Pfizer, Roche/Genentech, and Zentalis and funds for research support from AstraZeneca, Bayer, Bio-Path, Clovis Oncology, Cotinga, GlaxoSmithKline, Mereo, Novartis, and Roche/Genentech.